Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have.

Slides:



Advertisements
Similar presentations
Are topical NSAIDs a safe and effective treatment for Corneal Abrasions? Department of Emergency Medicine University of Pennsylvania Health System Andrew.
Advertisements

Delay in Symptom Resolution After Thermal Pulsation System Treatment for Meibomian Gland Dysfunction in Dry-Eye Disease Delay in Symptom Resolution After.
Non-Invasive Keratograph Tear Break-Up Time versus Invasive Fluorescein-Associated Tear Stability Test: Experimental Validation Study Nizar S Abdelfattah,
Impact of Conjunctivochalasis in Dry Eye
Epitheliopathy in the Region of the Eyelid Associated with the Caruncle in Normal Subjects and Dry-Eye Patients Epitheliopathy in the Region of the Eyelid.
Refractive Effects of Lamellar Keratectomy/Debridement for Corneal Surface Disorders Pre-Cataract Surgery Haresh Ailani MD, 1 Ira J. Udell MD, 1 Jules.
Yousef A Alghamdi, MD; Allison L McClellan, OD; Nabeel M Shalabi, MD Anat Galor, MD, MSPH Supported by the Department of Veterans Affairs, Veterans Health.
Astigmatism Following 2 IOL Injection Techniques: Wound Assisted Versus Wound Directed Jay J. Meyer, MD Hart B. Moss, MD Kenneth L. Cohen, MD University.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Macular Edema After Cataract Surgery Diabetic Retinopathy Clinical Research Network.
Placement of Toric Intraocular Lens and the Long-term Change in the Axis of Corneal Astigmatism after Sutureless Cataract Extraction by Phacoemulsification.
Young Joo Shin 1, Joo Hyun Kim 1, Jung Ha Kim 2, Woo Ho Nam 1, Kayoung Yi 1, Joon Young Hyon 3, 1 Department of Ophthalmology, Hallym University College.
W. B. Trattler; C. D. Reilly; D. F. Goldberg; P. A. Majmudar; J. A. Vukich; M. Packer; E. D. Donnenfeld.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Copyright restrictions may apply Sensitivity and Specificity of a Point-of-Care Matrix Metalloproteinase 9 Immunoassay for Diagnosing Inflammation Related.
Outcome of refractive surgery in keratoconus suspect eyes
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.
Association between Depression And Dry eye Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Young Joo Shin, MD, 1 Won Ryang Wee, MD, 2 Jin Hak Lee, MD, 1 1.
Blepharitis and Dry eyes in Aromatase Inhibitor Users
Dr. K.S.SIDDHARTHAN Aravind Eye Hospital Coimbatore
Bepotastine Besilate Ophthalmic Solution 1.5% and Degree of Reduced Ocular Itching in a Conjunctival Allergen Challenge Test JI Williams 1, G Torkildsen.
Effects of Xalatan® (latanoprost) or Travatan® (travoprost) on Ocular Surface Signs and Symptoms in Ocular Hypertensive or Glaucoma Patients. M.B. McDonald1,
Dr Umang Mathur, Dr Archana Gupta, Dr Suma Ganesh
Ocular Comfort Assessment of Bepotastine Besilate Ophthalmic Solution 1.5% in Multicenter Conjunctival Allergen Challenge Clinical Trial JA Gow 1, TT Macejko.
G. Jacob 1,2, C. Bouchard 2, S. Kancherla 1. Edward Hines, Jr. VA Hospital, Hines, IL, Department of Ophthalmology 1. Loyola University Medical Center,
Integrated Trial Results of Bepotastine Besilate Ophthalmic Solution 1.5% on Eyelid Swelling in a Clinical Model of Allergic Conjunctivitis TR McNamara.
Copyright restrictions may apply JAMA Ophthalmology Journal Club Slides: Trabeculectomy for Open-Angle Glaucoma Takihara Y, Inatani M, Ogata-Iwao M, et.
Correlation Between Corneal Biomechanics and Wavefront Aberrations Alejandro Rivera, MD Private Practice Mexico City The author has no financial interest.
Unilateral multifocal lens implantation in patients with a contralateral monofocal or phakic eye is a viable presbyopic correction option Robert J. Cionni,
ENESTnd Update: Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and the Impact.
Durezol™ (difluprednate ophthalmic emulsion) 0.05% BID or QID starting 1 day before cataract surgery for treatment of postoperative inflammation and pain.
Comparison of Bromfenac vs. Ketorolac During the Induction Phase of Treatment with Topical Cyclosporine for Dry Eye Patients Barry A. Schechter, MD Florida.
Blepharitis and Dry eyes in Aromatase Inhibitor Users Kiran Turaka, M.D. Kristin M. Hammersmith, M.D. Jennifer M. Nottage, M.D. Christopher J. Rapuano,
Evaluation of Systane® versus Placebo in Corneal Epithelial Healing Following Photorefractive Keratectomy (PRK) Lt Col Charles D. Reilly Major Vasudha.
Topical Cyclosporine for Postoperative use in PRK and LASIK: Preliminary Results LCDR David D. Hessert, M.D. Ophthalmology Chief Resident Naval Medical.
Cataract Surgery After Trabeculectomy: The Effect on Trabeculectomy Function Husain R, Liang S, Foster PJ. Cataract surgery after trabeculectomy: the effect.
Riley Hall BSc α, Robert Mitchell MD, FRCSC β University of Saskatchewan α, University of Calgary β Authors have no financial interest Comparison of postoperative.
Evaluation of refractive error measurements obtained by three different aberrometers Radha Ram, BA Li Wang, MD, PhD Mitchell P. Weikert, MD, MS Disclosure:
FLUORESCEIN CLEARANCE TEST AS AN ADDITIONAL DIAGNOSTIC TOOL FOR DYSFUNCTIONAL TEAR SYNDROME Rodrigo de Nápole Azevêdo, MD Jamília Barros da Silva, MD Aline.
Prospective Correlation of Symptoms and Clinical Grading in Vernal Keratoconjunctivitis Patients Srikant K Sahu, Shraddha Pawan Sureka, Sujata Das, Apurva.
Cole Eye Institute, Cleveland Clinic Foundation,
David R. Hardten 1, Mark Milner 2, Jai G. Parekh 3, Neda Shamie 4, Darrell E. White 5 and Michael Schiewe 6 Financial Disclosures: Dr’s Hardten, Milner,
Pattern of Pain and Analgesic use after Collagen Crosslinking for Progressive Keratoconus Ramon Coral Ghanem, MD, PhD. Renan Ferreira Oliveira, MD. Vinicius.
Peter A SimmonsA Cindy Carlisle-WilcoxA Perry S BinderB
Prevalence of Dry Eye Disease among Elderly Korean Population Sang Beom Han, MD, 1 Joon Young Hyon, MD, 1 Won Ryang Wee, MD, 2,3 Jin Hak Lee, MD, 1, 3.
Safety and efficacy of bromfenac ophthalmic solution 0.09% (Xibrom™) compared to prednisolone acetate 1% for treatment of ocular inflammation following.
Mean Keratometry Measurement Post Penetrating Keratoplasty Jacky Yeung MSc MD, Stephanie Baxter MD FRCS(C) Department of Ophthalmology, Hotel Dieu Hospital,
The authors have no financial interest in the subject matter of this poster. FINANCIAL DISCLOSURES.
Correlation of Conjunctival and Corneal Staining With Elevated Matrix Metalloproteinase-9 on the Ocular Surface of Dry-Eye Patients Authors: Allister Gibbons,
Incidence of Cataract Extraction After Corneal Transplantation in Young and Middle-Aged Patients Revathi Naadimuthu, MD Gerald W. Zaidman, MD Brandon Mirochnik,
Deep Anterior Lamellar Keratoplasty (DALK) Vs Penetrating Keratoplasty (PK) in patients with Keratoconus (KC). Dr. K.S.SIDDHARTHAN Aravind Eye Hospital.
Comparison of Central Corneal Thickness, Anterior Chamber Depth, and Central Corneal Power Measurements between Two Scheimpflug Imaging Systems Yuichi.
Comparison of Efficacy of 0.05% Cyclosporine Ophthalmic Emulsion
Prevalence of corneal astigmatism in cataract surgery candidates in Bangkok, Thailand Kaevalin Lekhanont, MD, Wadakarn Wuthisiri, MD, Porntip Chatchaipun,
Efficacy of Topical Azithromycin & Cyclosporine A(CsA) vs CsA Alone in the Treatment of Dry Eyes Associated with Blepharitis Kenneth A. Beckman, M.D.,
Comparing Factors Affecting Surgically Induced Astigmatism
Cost-Effectiveness of the Type II Boston Keratoprosthesis Jared D. Ament, MD, MPH, Tomasz P. Stryjewski, BS, Siddharth Pujari, PhD, George Papaliodus,
F.I. Camesasca, MD Zeiss Invent ZO Aspheric IOL: Long-Term Results of Refractive and Aberrometric Analysis F. I. Camesasca* P. Vinciguerra.
Poster produced by Faculty & Curriculum Support (FACS), Georgetown University School of Medicine LASIK Combined with Corneal Cross-linking in Eyes with.
Dissatisfication After Multifocal Intraocular Lens Implantation in Taiwan Yu Wei Lin, MD (Presenting Author); Ching-Ju Hsieh; Lin-Chung Woung The authors.
Liquifaction Method and Extent of Posterior Capsule Opacification: Two-Year Follow-up Marie Kalfertova, Mariya Burova, Pavel Rozsival, Nada Jiraskova Nada.
The Course of Dry Eye After Phacoemulsification Surgery Servet Cetinkaya 1, Emine Mestan 2, Nursen Oncel Acir 3, Yasemin Fatma Cetinkaya 4, Zeynep Dadaci.
CORNEAL ENDOTHELIAL PROFILE AFTER FERRARA RING IMPLANTATION Leonardo Torquetti, MD, PhD Paulo Ferrara, MD, PhD Paulo Ferrara Eye Clinic Belo Horizonte.
EVALUATION OF OCULAR SURFACE DISEASE IN PATIENTS AFTER TRABECULECTOMY: COMPARATIVE STUDY WITH AND WITHOUT INTRACAMERAL BEVACIZUMAB Sónia Parreira; Sandra.
A Randomised Cross Over Comparison of Trehalose/Hyaluronate Eye Drops and Standard Treatment: Patient Satisfaction in the Treatment of Dry Eye Syndrome.
Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD
The authors have no financial interest
Eric Dai MD, Pawan Prasher MD, James McCulley MD, R. Wayne Bowman MD.
Yumiko Ban,1,2,3) Seika Den,2) Jun Shimazaki,2,3)
The Effect of Corneal Thickness on Ocular Drug Penetration
I-Chan Lin MD, Paul P. Lee MD, JD
Presentation transcript:

Incidence of Blepharitis in Patients Undergoing Phacoemulsification Jodi Luchs, MD Carlos Buznego, MD William Trattler, MD The authors of this poster have received research funding and travel expense reimbursement from Inspire Pharmaceuticals. Jodi Luchs, MD and William Trattler, MD are consultants for Inspire Pharmaceuticals.

Abstract TITLE: Prevalence of Blepharitis in Patients Scheduled for Routine Cataract Surgery Authors: Jodi I. Luchs, Carlos Buznega, William B. Trattler Purpose: The primary objective of this observational study is to determine the prevalence of blepharitis in patients preparing to undergo routine cataract surgery. There are currently no studies available which document the prevalence of blepharitis in patients who undergo cataract surgery. Methods: Patients were assessed at one of two study sites prior to the date of their cataract surgery. Procedures included: Patient-rated assessments of symptoms of blepharitis, investigator-rated signs of blepharitis, biomicroscopy, fluorescein tear break- up time (TBUT), and fluorescein corneal staining. No investigational drug was utilized in this study. Results: A total of 100 patients were evaluated in this study. The overall prevalence rate of blepharitis in patients preparing to undergo cataract surgery was determined to be 59 out of 100 patients (59%). On average, patient’s signs and symptoms of blepharitis were determined to be mild to moderate. The tear film break up time was found to be below the normal range. Conclusion: In this prospective study, blepharitis was determined to have a high prevalence in patients preparing to undergo cataract surgery. Blepharitis may be frequently overlooked in these patients due to mild or moderate signs and symptoms, although its effect on the ocular surface may have important implications for the upcoming surgery.

Introduction Both Anterior and posterior blepharitis are common ocular surface disorders, which may be frequently overlooked, yet may have a significant impact on the outcomes of ocular surgery. This study evaluated the prevalence of blepharitis in patients undergoing routine cataract surgery.

Methods Prospective, multicenter observational study which assessed the incidence of blepharitis in 100 patients scheduled to undergo cataract surgery. Patients were consented and evaluated at the time that they presented for pre-operative biometry. Outcome measures: –The presence or absence of blepharitis (presence of at least 2 clinical signs of blepharitis, at least one of which had a severity score of ≥2) –Total blepharitis symptom severity score (total symptom scores for itch, foreign body sensation, dryness, burning or pain, and swollen/heavy eyelids) –Blepharitis clinical sign severity scores for lid debris, lid swelling, meibomian gland plugging, and quality of meibomian gland secretions. –Degree of ocular surface fluorescein staining (NEI grading system 1 ) –Tear film break up time

Patient Demographics 59% of patients were diagnosed with blepharitis Mean age was 72.4 years (range: 52-88)

Mean Symptom Score *P=.238

Clinical Signs of Blepharitis * * * * *P<.001

Mean TBUT *P=.076

Distribution of TBUT Scores <<< P=.026

Mean Corneal Staining *P=.082 *Range = 0-15

Discussion –Blepharitis is one of the most common conditions encountered by eye care professionals, although it may be frequently overlooked. It is important to recognize and treat this condition pre-operatively in patients about to undergo ocular surgery in order to potentially reduce the risk of post-operative infection, 2-4 as well as to stabilize the tear film in order to ensure accurate pre-operative keratometry, topography or wavefront analysis. Post-operatively, untreated posterior blepharitis may also contribute to worsening of post-operative dry eye, fluctuating vision or a slower recovery of vision. –This study found that 59% of patients undergoing routine evaluation for cataract surgery had clinical signs of blepharitis, making it a commonly occurring condition. However it should be pointed out that that the overall clinical sign and symptom scores were low for this cohort of patients with blepharitis, averaging approximately 2 on a scale of 0-4. Consequently, it is possible that this condition is frequently overlooked due to the fact that patients with mild symptoms may not complain, and mild clinical signs my be overlooked the clinician. –However, there is a real disturbance to the tear film in these patients with blepharitis as demonstrated by the statistically significant greater number of patients with blepharitis in this study who had a tear film break-up time of 5 seconds or less. This may have important implications for patients undergoing ocular surgery. –While there was a trend towards greater mean corneal staining scores in patients with blepharitis, the difference was not statistically significant. This difference might have approached statistical significance with a larger sample size. Furthermore, this observational study did not control for the presence of other ocular surface diseases, such as dry eye in either group which might confound these results.

Conclusions The incidence of blepharitis is under-reported –The symptom scores and clinical sign scores are low, so the condition may be frequently overlooked –However, there is a real disturbance of the ocular surface as evidenced by the more rapid TFBUT in these patients. This can have potentially important implications for pre-operative measurements and post-operative outcomes of cataract and refractive surgery. REFERENCES: 1 Lemp MA. Report of National Eye Institute/Industry Work shop on clinical trials in dry eyes. C L A O J 1995;21: EVS Study Group: Arch Ophthalmol 1995;113(12): Solomon et. al.: J Cataract Refract Surg. 2003;29: Speaker MG et al.: Ophthalmology 1991;98(5):